Frank J. Hsu - Oct 7, 2022 Form 4 Insider Report for Apexigen, Inc. (APGN)

Role
Chief Medical Officer
Signature
/s/ Francis Sarena, by power of attorney
Stock symbol
APGN
Transactions as of
Oct 7, 2022
Transactions value $
$0
Form type
4
Date filed
10/11/2022, 04:53 PM
Previous filing
Aug 8, 2022
Next filing
Dec 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APGN Common Stock Award $0 +25K $0.00 25K Oct 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGN Employee Stock Option (right to buy) Award $0 +27K $0.00 27K Oct 7, 2022 Common Stock 27K $2.46 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are represented by restricted stock units, or RSUs, which vest in two equal installments on December 15, 2022 and June 15, 2023.
F2 The shares subject to the option vest in 48 equal monthly installments beginning on February 1, 2022.